Clinical Trials Directory

Trials / Completed

CompletedNCT00763100

Efficacy of Tomosynthesis in the BIRADS 3 Population

The Efficacy of Tomosynthesis in the BIRADS 3 Population Including Surveillance of Patients in the Treatment or Post-Treatment for Breast Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
690 (estimated)
Sponsor
WellSpan Health · Academic / Other
Sex
Female
Age
26 Years
Healthy volunteers
Not accepted

Summary

There are three main objectives, centering on those patients targeted for surveillance imaging. The first objective is to compare image quality and specificity of breast tomosynthesis and conventional 2D mammography in a BIRADS 3 diagnostic population. The second objective is to compare image quality and ability to determine post-surgical and post-radiation changes from recurrence in a post-cancer subset of a BIRADS 3 population having undergone conservation therapy (lumpectomy with or without radiation. The final objective is to compare image quality and the ability to determine chemoresponsiveness in a post-cancer subset of a BIRADS 3 population, who are undergoing neoadjuvant chemotherapy.

Conditions

Timeline

Start date
2008-05-01
Primary completion
2009-11-01
Completion
2009-11-01
First posted
2008-09-30
Last updated
2011-01-06

Source: ClinicalTrials.gov record NCT00763100. Inclusion in this directory is not an endorsement.

Efficacy of Tomosynthesis in the BIRADS 3 Population (NCT00763100) · Clinical Trials Directory